An overview on age relate d macular degeneration and recent advances in its management

Age-related macular degeneration (AMD) is a...

Age-related macular degeneration (AMD) is a condition characterized, in the early stages, by slow development and progression, absence of symptoms over a number of years, and extensive retinal deposits called drusen, often associated with pigmentary abnormalities (early AMD).There is strong and consistent evidence that increasing age, family history, obesity/high body mass index, and cataract surgery are associated with late AMD.
Smoking is the strongest and most consistently found modifiable risk factor for late AMD.Age-related macular degeneration remains one of the most severe and profound disabilities encountered in medicine, particularly due to the loss of the central vision and the high economic burden it places on patients and societies.Recent advances in
management of AMD is anti-angiogenic drugs. The identification of the crucial role played by vascular endothelial growth factor (VEGF) in the pathogenesis of wet AMD hasallowed the development of VEGF-blocking agents such as bevacizumab, pegaptanib and ranibizumab.

| info visites 9161281

Suivre la vie du site fr  Suivre la vie du site Chimie  Suivre la vie du site PhytoChem & BioSub Journal  Suivre la vie du site Volume 8  Suivre la vie du site Numéro1   ?

Creative Commons License